Search

Arrowhead Pharmaceuticals Inc

Fechado

SetorSaúde

71.25 -4.16

Visão Geral

Variação de preço das ações

24h

Atual

Mín

71.59

Máximo

74.62

Indicadores-chave

By Trading Economics

Rendimento

-161M

-133M

Vendas

-190M

74M

P/E

Médio do Setor

47.744

60.549

EPS

-0.93

Margem de lucro

-180.007

Funcionários

711

EBITDA

-165M

-107M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+21.74% upside

Dividendos

By Acuity

Próximos Ganhos

6 de ago. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

1.5B

12B

Abertura anterior

75.41

Fecho anterior

71.25

Sentimento de Notícias

By Acuity

67%

33%

307 / 342 Ranking em Healthcare

Arrowhead Pharmaceuticals Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

13 de jul. de 2026, 23:41 UTC

Correlated Moves
News
Macro News
ETF Constituents

Vanguard Information Technology ETF declined in after-market hours amid rising crude oil prices and negative sentiment from Oracle's losses, impacting major tech stocks.

13 de jul. de 2026, 23:26 UTC

News

Shares of Netflix are higher in after-market hours as options traders make bullish bets ahead of the earnings report on July 16.

13 de jul. de 2026, 23:16 UTC

News

Marriott International will release second-quarter 2026 earnings on August 3, 2026. Shares are higher in after-hours trading, though near the lower end of their range.

13 de jul. de 2026, 23:11 UTC

News

USD/THB is advancing in Monday's session, supported by a recovery from earlier lows. Rising inflation concerns are influencing market dynamics ahead of upcoming reports.

13 de jul. de 2026, 23:06 UTC

Social Media
News

Biogen received FDA approval for LEQEMBI IQLIK, a subcutaneous Alzheimer's treatment, boosting shares modestly higher in after-market trading.

13 de jul. de 2026, 22:51 UTC

News

Vanguard Mortgage-Backed Securities ETF is trading lower in after-market hours, influenced by rising crude oil prices and concerns over inflation and interest rates.

13 de jul. de 2026, 22:51 UTC

News

The USD/ZAR is trading higher amid geopolitical tensions following U.S. strikes against Iran, maintaining strength near its one-month range.

13 de jul. de 2026, 22:31 UTC

News
ETF Constituents

Vanguard Growth ETF trades higher in after-market hours, supported by Nvidia and Texas Instruments, amid rising crude oil prices and inflation concerns.

13 de jul. de 2026, 22:31 UTC

News
Correlated Moves

iShares 7-10 Year Treasury Bond ETF rises slightly after market close, amid rising crude oil prices and inflation concerns influencing broader market volatility.

13 de jul. de 2026, 22:21 UTC

News

Vanguard Total Bond Market ETF is modestly higher in after-market trading as crude oil prices rise amid escalating U.S.-Iran military tensions.

13 de jul. de 2026, 22:01 UTC

News

The USD/HUF is gaining, reaching a session high as rising oil prices heighten inflation concerns and potential Federal Reserve interest rate hikes.

13 de jul. de 2026, 21:51 UTC

Correlated Moves
News

The iShares 20+ Year Treasury Bond ETF is slightly higher in after-market trading as rising U.S. Treasury yields follow President Trump's Iranian blockade announcement.

13 de jul. de 2026, 20:21 UTC

Correlated Moves
News
ETF Constituents

The Russell 2000 Index is modestly lower after-market, reflecting broader market declines amid U.S.-Iran tensions. Vanguard Small-Cap ETF remains little changed.

13 de jul. de 2026, 20:07 UTC

Social Media
News

American Airlines Group shares are lower amid concerns over high debt and disappointing revenue passenger miles, despite some optimistic social media discussions.

13 de jul. de 2026, 20:07 UTC

News
Correlated Moves

Ethereum is trading lower as geopolitical tensions raise inflation concerns and increase market volatility. The cryptocurrency fell from an earlier session high.

13 de jul. de 2026, 20:07 UTC

Correlated Moves
News

Ethereum is trading lower as geopolitical tensions raise inflation concerns and increase market volatility. The asset remains above its 20-day moving average.

13 de jul. de 2026, 20:07 UTC

News
Correlated Moves
Social Media

The Polish zloty has weakened, contributing to a modest rise in USD/PLN since Friday's close amid increased military tensions and inflation concerns.

13 de jul. de 2026, 20:07 UTC

News
Correlated Moves

Silver/NZD declines amid rising inflation concerns linked to surging crude oil prices and fears of interest rate hikes. The asset has closed lower for three sessions.

13 de jul. de 2026, 20:07 UTC

Correlated Moves
News

Silver is declining amid rising inflation concerns linked to crude oil prices and U.S.-Iran tensions. The asset has pulled back from earlier session gains.

13 de jul. de 2026, 20:07 UTC

News
Correlated Moves

Silver Ounce vs Euro is declining amid rising inflation concerns linked to crude oil prices and U.S.-Iran tensions, marking three consecutive sessions lower.

13 de jul. de 2026, 20:07 UTC

Correlated Moves
News

Silver declines amid rising inflation concerns and crude oil price surge. The asset has pulled back from earlier gains, continuing a downward trend.

13 de jul. de 2026, 20:07 UTC

News
Correlated Moves

Silver declines amid rising inflation concerns linked to crude oil prices. The asset has pulled back from earlier gains and remains below its 20-day moving average.

13 de jul. de 2026, 20:07 UTC

News
Correlated Moves

USD/CZK is trading higher, supported by broader gains and approaching the upper end of its one-month range amid inflation data and Federal Reserve policy focus.

13 de jul. de 2026, 20:07 UTC

News
Correlated Moves

The US Dollar Index's rise supports USD/DKK, which is higher since Friday's close. Concerns over U.S.-Iran military actions impact market sentiment.

13 de jul. de 2026, 20:06 UTC

News

Fiserv shares are higher as leadership changes prompt analysts to monitor potential impacts. The company is also considering the sale of its STAR payment network.

13 de jul. de 2026, 20:06 UTC

News
Social Media

MercadoLibre opens a new distribution center in Nuevo León, Mexico, creating over 2,000 jobs and enhancing logistics amid rising e-commerce demand. Shares are higher.

13 de jul. de 2026, 20:06 UTC

News

Gold is trading higher, supported by inflation concerns linked to rising crude oil prices amid U.S.-Iran tensions. Silver has declined after earlier gains.

13 de jul. de 2026, 20:06 UTC

Correlated Moves
News

The USD/SGD is trading higher, reflecting strength near its one-month range. Broader market dynamics and geopolitical tensions are influencing currency movements.

13 de jul. de 2026, 20:06 UTC

Correlated Moves
News

The USD/SEK is trading higher, influenced by broader currency market movements and concerns over supply disruptions in the Strait of Hormuz.

13 de jul. de 2026, 20:06 UTC

News
Correlated Moves

Silver/JPY is declining amid rising inflation concerns linked to crude oil prices and escalating U.S.-Iran tensions. The asset has traded lower for three consecutive sessions.

Comparação entre Pares

Variação de preço

Arrowhead Pharmaceuticals Inc Previsão

Preço-alvo

By TipRanks

21.74% parte superior

Previsão para 12 meses

Média 90.22 USD  21.74%

Máximo 110 USD

Mínimo 46 USD

Com base em 10 analistas de Wall Street que oferecem metas de preço de 12 meses para Arrowhead Pharmaceuticals Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

10 ratings

9

Comprar

1

Manter

0

Vender

Sentimento

By Acuity

307 / 342 Ranking em Saúde

Sentimento de Notícias

Evidência de Tendência de Baixa

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Arrowhead Pharmaceuticals Inc

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes Plozasiran, which is in Phase 2b and one Phase 3 clinical trial to treat hypertriglyceridemia, mixed dyslipidemia, and chylomicronemia syndrome; Zodasiran that is in Phase 2b clinical trial for the treatment of dyslipidemia and hypertriglyceridemia; ARO-PNPLA3, which is in Phase 1 clinical trial to treat patients with non-alcoholic steatohepatitis; ARO-RAGE that is in Phase 1/2a clinical trial to treat inflammatory pulmonary conditions; and ARO-MUC5AC, which is in Phase 1/2a clinical trial to treat muco-obstructive pulmonary diseases. It also develops ARO-MMP7 that is in Phase 1/2a clinical trial for treatment of idiopathic pulmonary fibrosis; ARO-DUX4 for the treatment of facioscapulohumeral muscular dystrophy; ARO-SOD1 for the potential treatment of amyotrophic lateral sclerosis; and ARO-C3, which is in Phase 1/2a clinical trial for the treatment of patients with various complement mediated or complement associated renal diseases. In addition, the company is involved in the development of JNJ-3989, which is in Phase 2 clinical trial to treat chronic hepatitis B virus infection; Olpasiran that is in Phase 3 clinical trial to reduce the production of apolipoprotein A; GSK-4532990 that is in phase 2 clinical trial to treat liver diseases; HZN-457, which is in phase 1 clinical trial to treat uncontrolled gout; and Fazirsiran that is in Phase 3 clinical trial for the treatment for liver disease associated with alpha-1 antitrypsin deficiency. Arrowhead Pharmaceuticals, Inc. has license and research collaboration agreements with Janssen Pharmaceuticals, Inc.; Takeda Pharmaceutical Company Limited; Horizon Therapeutics Ireland DAC; Amgen Inc.; and Glaxosmithkline Intellectual Property (No. 3) Limited. The company was founded in 2003 and is headquartered in Pasadena, California.
help-icon Live chat